Association for Molecular Pathology                       
Newsletter                                                                
   
February 2010, Volume 16, Number 1 

Inside this Issue

Front Page
President's Message
Special Features
• AMP 2009 Leadership Awardee
• AMP Award for Excellence in
  Molecular Diagnostics
• Executive Officer's Report
• Photo Contest Winners
• Annual Meeting Photo Album
• CHAMP
• JMD Report
• Web Editorial Board
Young Investigator Awards
• 2009 Young Investigator Awardees
Tech Corner
• 2009 Technologist Awardees
• 2009 Technologist Travel Awardees
Committee Reports
• Clinical Practice Committee
• Economic Affairs Committee
• Membership & Professional   
  Development Committee
• Nominating Committee
• Professional Relations
  Committee
• Program Committee
• Publications Committee
• Training & Education Committee
Subdivision Reports
• Genetics
• Hematopathology
• Infectious Diseases
• Solid Tumors
2010 AMP Officers and Appointees

Infectious Diseases Subdivision Report

David H. Persing, MD, PhD

By David H. Persing, MD, PhD
Chair, Infectious Diseases Subdivision

e-mail: david.persing@cepheid.com

On behalf the Infectious Disease Subdivision, Chair-elect Randy Hayden and I would like to thank Rick Nolte for his outstanding leadership in 2008-2009.  From program development to abstract evaluation, Rick demonstrated a commitment to AMP’s leadership in molecular diagnostics for infectious diseases applications, and his efforts were rewarded by highly informative and effective sessions at the Annual Meeting.  We also wish to extend our gratitude to outgoing Clinical Practice Committee representative Belinda Yen-Lieberman, Nominating Committee representative Randy Hayden, and Training and Education Committee Representative Matt Bankowski for their service during the year. Our 2010 Committee Representatives are Donna Wolk and Jeff Wisotzkey (Clinical Practice Committee), Jeanne Carr and Preeti Pancholi (Nominating Committee), and Carol Holland and Janice Matthews-Greer (Training and Education Committee).

Randy and I are in the midst of the final stages of the preparation for the 2010 Meeting in San Jose, CA.  In the Plenary Session we are proposing to focus on the impact of pathogen discovery techniques, specifically broad-range PCR, in defining or re-defining the etiologic basis for two infectious conditions: 1) Whipple’s disease (admittedly esoteric but on the differential diagnosis of myriad conditions), and 2) Bacterial vaginosis, an exceedingly common but poorly understood condition, the etiology of which has been redefined by PCR and high-throughput sequencing.  In the Infectious Diseases Workshop we propose to focus on verification, validation and implementation of quantitative nucleic acid detection methods, an important area for those of you offering viral load testing.  Additional infectious-diseases related topics will likely appear at other times during the Meeting; details to follow.